• Aucun résultat trouvé

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.

N/A
N/A
Protected

Academic year: 2021

Partager "BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease."

Copied!
17
0
0

Texte intégral

Références

Documents relatifs

HCV mono-infected patients, HIV-/HCV+ patients; cART, combined anti-retroviral therapy; AFP, α-foetoprotein; US, ultrasonography; AASLD, American Association for the Study

proportion of patients having the NS5A V3 insertion increased with liver disease severity (no 174. cirrhosis, cirrhosis without HCC, cirrhosis with

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des

Next, we developed conditional Poisson regression mod- els, with robust modification of the error variance, to estimate the adjusted prevalence rate ratio (adjusted by matching)

High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262)... High Proportion of

For the prediction of liver ‐ related death the number of events at 10 years was too small (n = 7) for any conclusion. Therefore, the primary aim was to assess the prognostic value

Our scaling relation fits a large range of experimental data obtained for completely different nanoemulsion systems and prepared through different techniques. Also, the dimensionless

prospective cohort study of patients with HCV-associated CryoVas treated with pegylated interferon-α plus ribavirin found that patients who received rituximab prior to antiviral